CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: ATX-MS-1467 in Multiple Sclerosis [Phase 2]

Phase 2 clinical trial update for ATX-MS-1467 in multiple sclerosis; the study completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13